News

Health and Human Services Secretary Robert F. Kennedy Jr. last month told a congressional panel that the administration was ...
In April 2025, Tonix Pharmaceuticals and Makana Therapeutics announced a collaboration combining Tonix's TNX-1500 with Makana ...
United Therapeutics (UTHR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...
United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...
Against that backdrop, United Therapeutics is facing specific questions about near-term sales performance, particularly ...
Douglas E. Williams, Ph.D. Strong track record at executive and board level of building company value across all stages of ...
A joint guideline released today from the Endocrine Society and the European Society of Endocrinology (ESE) recommends women ...
The Philadelphia gene therapy company said the cuts were "part of a broader effort to right size the organization." ...
In the last three months, 9 analysts have published ratings on United Therapeutics (NASDAQ:UTHR), offering a diverse range of perspectives from bullish to bearish. The table below offers a ...